Physician profile
Sindy Fox
NPI 1013719780
$587.73
in general payments reported to CMS, 2019-2025
16 companies · $588 in 2025
The $588 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $69.77 | 2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $49.34 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $49.14 | 2025 | |
| Amgen INC. | $47.89 | 2025 | Evenity, Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $46.20 | 2025 | Trintellix |
| Novo Nordisk INC | $45.88 | 2025 | Wegovy, Rybelsus, Ozempic |
| Sumitomo Pharma America, INC. | $45.88 | 2025 | Gemtesa |
| Corcept Therapeutics | $36.85 | 2025 | Korlym |
| Teva Pharmaceuticals USA, INC. | $34.37 | 2025 | Austedo Xr |
| Lilly USA, LLC | $34.13 | 2025 | Kisunla, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $32.04 | 2025 | Airsupra, Breztri |
| Dexcom, INC. | $24.87 | 2025 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $22.69 | 2025 | Licart, Flector, Tirosint |
| Pfizer INC. | $16.84 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.48 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $15.36 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sindy Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.